Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Dogfish Head & Dan-O’s Seasoning to Debut Limited-Edition Grilling Kit
-
Dogfish Head & Dan-O’s Seasoning to Debut Limited-Edition Grilling Kit
-
HERTZ GLOBAL HOLDINGS, INC. (NASDAQ: HTZ) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Hertz Global Holdings, Inc.
-
New Weight Loss Drugs Pose Anesthesia Risk, according to Journal of American Physicians and Surgeons
-
Declaration made pursuant to Article L. 233-8-II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers
-
Pepper Lunch Announces First Florida Restaurant to Open Soon
-
PruittHealth Again Certified as a Great Place to Work®
-
Three-Segment Collection From Accompolished Author Brings Joy, Adventure, and Fun To Readers
-
Arctic Wolf Wins Best SME Security Solution at 2024 SC Awards Europe
-
533 Students Receive Student Impact Award
-
INVESTOR ALERT: DiCello Levitt LLP Announces the Filings of a Class Action Against Humana Inc. (NYSE: HUM)
-
Mandatory Notification of Trade
-
Alliance Trust PLC - Transaction in Own Shares
-
PPC.io Raises $5M in Seed Funding To Revolutionize PPC Marketing
-
Joint Commission–Accredited Long-Term Care Hospitals Perform Significantly Better on Key Infection Control Measures
-
TOMI Environmental Solutions, Inc. Announces Cost Reduction Efforts to Sustain Long Term Growth and Achieve Profitability
-
B2BinPay v20 Release: Improved Functionality with TRX Staking and Expanded Blockchain Support
-
ChildCare Education Institute Offers No-Cost Online Course on Discovering Life Science with Young Children
-
OFL to TTC: ‘Get a deal now, or expect more than TTC workers on picket lines tomorrow’
-
THE NEWS FORUM - Why aren’t the UN and Egypt building field hospitals across the Rafah border to help wounded Palestinian civilians - especially children?
-
CN Formally Offers Binding Arbitration to TCRC
-
CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC
-
Vallourec signs a major contract for the supply of tubes and services to Petrobras
-
Transaction in Own Shares
-
Jack’s Basket and Global Down Syndrome Foundation Collaboration To Provide More Resources to Families in the US and Around the World
-
Mortgage Rates Pull Back
-
Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital
-
Haffner Energy teams up with LanzaJet for “Paris-Vatry SAF”
-
Market update : FOCUS-27 transformation project financing
-
Electrify Expo Shatters Records with Unprecedented Number of Demos and Attendance, Disrupting the Anti-EV Narrative
-
QXO Announces Leadership Team and Board of Directors
-
Middlefield Canadian Income PCC: Net Asset Value(s)
-
QXO Completes $1 Billion Equity Investment
-
Sodexo - Disclosure of transactions in own shares carried out on June 3, 2024
-
VINCI acquires a 20% shareholding in the Budapest airport concession company and becomes the platform operator
-
Wawa Officially Breaks Ground on First Store in Ohio
-
Swift Navigation and Locosys Partner to Deliver Unmatched Price-to-Performance in Precise GNSS Positioning for IoT Applications
-
Nexans completes acquisition of La Triveneta Cavi, expanding European reach
-
Mint Eco Car Wash and Detail Center Celebrates Grand Opening of Fifth Location
-
ACT Foundation congratulates Quebec Minister of Education on announcement to expand AEDs to all public schools
-
KIC Realty Announces Removal of Cap for KARE – KIC Agent Retirement Equity Plan
-
Purchase of Own Securities and Total Voting Rights
-
Form 8.5 (EPT/RI) - Alpha Financial Markets Consulting plc
-
Barinthus Bio's VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B
-
Barinthus Bio's VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B
-
Treatment with Arbutus’ Imdusiran and VTP-300 Achieves Statistical Significance in Lowering HBsAg Levels
-
Oceana and Actor Dennis Haysbert Team Up in New PSA for National Oceans Month
-
Lowey Dannenberg Notifies Fastly, Inc. (“Fastly” or the “Company”) (NYSE: FSLY) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contac
-
Legend Senior Living Assumes Management, Renames Four Florida Properties, Increases Portfolio to 59
-
Director Declaration
